BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
BioAge Labs price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioAge Labs's price to sales ratio was 25.9× on Nov 11, 2026, against 57.5× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 25.9× | −54.2 |
| 2025 | Dec 31, 2025 | 80.2× | – |
See a number that looks wrong?